31 January 2019 - PhRMA president and CEO Stephen J. Ubl has issued a statement.

“We applaud the Administration for taking steps to reform the rebate system to lower patients’ out-of-pocket costs. Our current health care system results in patients often paying cost-sharing based on the list price, regardless of the discount their insurer receives. We need to ensure that the $150 billion in negotiated rebates and discounts are used to lower costs for patients at the pharmacy.

“This proposal would also help to fix the misaligned incentives in the system that currently result in insurers and pharmacy benefit managers favouring medicines with high list prices."

Read PhRMA press release